Novaplex™ MTB/MDR Detection
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)
Description
Targets 4
Sample Type
- Sputum
- Cultured cells
- Fresh tissue in the sample types
- Bronchial wash
Key Features
- Simultaneous detection of Mycobacterium tuberculosis and over 30 mutations associated with drug-resistance TB
- Informative MTB result with Ct value and qualitative drug-resistance result in a single test
Compatible instrumentation
Auto Extraction & PCR Setup
- Seegene NIMBUS
- Seegene STARlet
Real-time PCR
- CFX96 Real-time PCR Detection System (Bio-Rad)
- CFX96 Dx (Bio-Rad)
- CFX96 Touch (Bio-Rad)
- CFX96 Opus (Bio-Rad)
Seegene Viewer Software
- Quick and easy data analysis and interpretation
- Interface specialized for multiplex testing
• Novaplex™ Assays are for Research Use Only. Not for use in diagnostic procedures. • Seegene NIMBUS, Seegene STARlet, Seegene Launcher and Viewer software are For Research Use Only. Not for Use in Diagnostic Procedures.
Additional information
| Volume | 124 rxns |
|---|
Related products
-
Targets
- Mycoplasma genitalium (MG)
- G248A (mutation of parC)
- A247C (mutation of parC)
- G248T (mutation of parC)
- G259A (mutation of parC)
- G259C (mutation of parC)
- G259T (mutation of parC)
-
Targets
- Carbapenemase genes (NDM)
- Carbapenemase genes (KPC)
- Carbapenemase genes (OXA48)
- Carbapenemase genes (VIM)
- Extended Spectrum Beta Lactamase gene (ESBL)
- Carbapenemase genes (IMP)
- CTX-M genes
- Vancomycin resistance genes (VanA, VanB) genes
-
Targets
- Mycobacterium tuberculosis (MTB)
- Extensive drug resistance (13 mutations)
- Injectable drug-resistance (6 mutations)
- Fluoroquinolone-resistance (7 mutations)
-
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)